Drug-independent NADPH-consuming micelles collaborate with ROS-generator for cascade ferroptosis amplification by impairing redox homeostasis

[1]  M. Pešić,et al.  The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance , 2022, Frontiers in Molecular Biosciences.

[2]  Chun‐Xia Zhao,et al.  FRET Ratiometric Nanoprobes for Nanoparticle Monitoring , 2021, Biosensors.

[3]  Y. Luan,et al.  Nanoengineering of a newly designed chlorin e6 derivative for amplified photodynamic therapy via regulating lactate metabolism. , 2021, Nanoscale.

[4]  Jiandong Zhang,et al.  Inhibition of GPX4 or mTOR overcomes resistance to Lapatinib via promoting ferroptosis in NSCLC cells. , 2021, Biochemical and biophysical research communications.

[5]  Tingting Meng,et al.  Self-preparation system using glucose oxidase-inspired nitroreductase amplification for cascade-responsive drug release and multidrug resistance reversion. , 2021, Biomaterials.

[6]  Jun Zhang,et al.  Smart biomimetic metal organic frameworks based on ROS-ferroptosis-glycolysis regulation for enhanced tumor chemo-immunotherapy. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[7]  K. Tonissen,et al.  Investigating the Thioredoxin and Glutathione Systems’ Response in Lymphoma Cells after Treatment with [Au(d2pype)2]Cl , 2021, Antioxidants.

[8]  D. Krysko,et al.  Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future , 2021, Journal for ImmunoTherapy of Cancer.

[9]  Xiang Song,et al.  Role of GPX4-Mediated Ferroptosis in the Sensitivity of Triple Negative Breast Cancer Cells to Gefitinib , 2020, Frontiers in Oncology.

[10]  S. Fulda,et al.  Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma , 2020, Translational oncology.

[11]  Dhanya Sunil,et al.  Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[12]  M. Xie,et al.  Role of hypoxia in cancer therapy by regulating the tumor microenvironment , 2019, Molecular Cancer.

[13]  Jingqing Yang,et al.  Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death , 2019, Nature Communications.

[14]  B. Stockwell,et al.  The Hallmarks of Ferroptosis , 2019, Annual Review of Cancer Biology.

[15]  Hong Yuan,et al.  Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy , 2019, International journal of nanomedicine.

[16]  Ting Duan,et al.  RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer , 2018, Front. Pharmacol..

[17]  Liming Nie,et al.  Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. , 2016, Chemical Society reviews.

[18]  S. Dixon,et al.  Mechanisms of ferroptosis , 2016, Cellular and Molecular Life Sciences.

[19]  Hong Yuan,et al.  Selective redox-responsive drug release in tumor cells mediated by chitosan based glycolipid-like nanocarrier. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Duxin Sun,et al.  Noninvasive fluorescence resonance energy transfer imaging of in vivo premature drug release from polymeric nanoparticles. , 2013, Molecular pharmaceutics.